Business
NOLA_B: Q2 sales up 4% to SEK 2.4B, with margin and profit growth driven by Medical and Engineered Solutions
NOLA_B: Q2 sales up 4% to SEK 2.4B, with margin and profit growth driven by Medical and Engineered Solutions
About this update from Nolato Ab Class B
Sales grew 4% year-over-year to nearly SEK 2.4 billion, with EBITDA margin up to 11.6% and operating profit rising 13%. Medical Solutions led growth, supported by global expansion and margin improvements, while Engineered Solutions saw gains in consumer electronics and hygiene.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.